Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3800
+0.0267 (7.56%)
At close: Nov 3, 2026, 4:00 PM EST
0.3800
0.00 (0.00%)
Pre-market: Nov 4, 2026, 5:00 AM EST

Co-Diagnostics Revenue

Co-Diagnostics had revenue of $166.13K in the quarter ending June 30, 2026, with 1.98% growth. This brings the company's total for the last twelve months to $721.39K, down -28.12% year-over-year. In the year 2025, Co-Diagnostics had annual revenue of $622.49K, down -84.10%. That makes Co-Diagnostics the 44,100th largest company in the world by revenue and 6,213th in the United States.

Revenue (ttm)
$721.39K
Revenue Growth
-28.12%
P/S Ratio
4.19
Revenue / Employee
$6,273
Employees
115
Market Cap
3.02M

Revenue Chart

Revenue by Geography

  • United States 581.55K 93.4%
  • Rest of World 40.94K 6.6%
Fiscal year ended Dec 31, 2025 See the full Co-Diagnostics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025622.49K-3.29M-84.10%
Dec 31, 20243.92M-2.90M-42.53%
Dec 31, 20236.81M-27.41M-80.09%
Dec 31, 202234.22M-63.67M-65.04%
Dec 31, 202197.89M23.33M31.30%
Dec 31, 202074.55M74.34M34,579.90%
Dec 31, 2019214.97K175.06K438.63%
Dec 31, 201839.91K32.25K420.90%
Dec 31, 20177.66K--
Dec 31, 2016---
Dec 31, 201510.00K--
Dec 31, 2014---